Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

Aspira Women's Health Inc.

CIK 926617 AWHL·Manufacturing · All EDGAR filings ↗

Progression

  1. Late filing NT 10-K
  2. Finance chief departure 8-K +29d
Finance chief departure Filing comparison

Aspira Women's Health Inc.'s Chief Financial Officer departed and a successor was named

Evidence
Interim only
No
Item code
5.02
Item title
Departure of Directors or Certain Officers
Role
Chief Financial Officer
Severity
normal
Source
SEC 8-K item code
Successor named
Yes
Why
The company's chief financial or accounting officer departed, disclosed under 8-K Item 5.02.

Source filing ↗

Late filing elevated Filing comparison

Aspira Women's Health Inc. told the SEC it could not file its annual report on time

Does not expect a significant change in results. 1 day past the statutory due date.

The Company needs more time to complete the accounting for its Annual Report on Form 10-K for the year ended December 31, 2025 within the prescribed time period because the Company needs more time to complete the accounting for and disclosures related to its tax provision for the year ended December 31, 2025. The Company expects to file the Form 10-K within the extension period of 15 calendar days.
Evidence
Anticipates significant change
No
Days past due date
1
Other periodic reports filed
Yes
Routine
No
Severity
elevated
Source
Form 12b-25 (notification of late filing)
Stated reason
The Company needs more time to complete the accounting for its Annual Report on Form 10-K for the year ended December 31, 2025 within the prescribed time period because the Company needs more time to complete the accounting for and disclosures related to its tax provision for the year ended December 31, 2025. The Company expects to file the Form 10-K within the extension period of 15 calendar days.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗